pan-RAS drugs for Non-Small Cell Lung Cancer

3 tracked pan-RAS drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the pan-RAS page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

1 Phase 31 Phase 21 Phase 1/2

The roster

← all pan-RAS drugs